Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/16943| Title: | Assessing the value of a new pharmaceutical |
| Authors: | O'Brien, Bernie J. Centre for Health Economics and Policy Analysis |
| Keywords: | Cost-Benefit Analysis;Economics, Pharmaceutical;Feasibility Studies;Granulocyte Colony-Stimulating Factor;Managed Care Programs;Neoplasms;drug therapy;Patient Acceptance of Health Care;Relative Value Scales |
| Publication Date: | 1996 |
| Publisher: | McMaster University |
| Series/Report no.: | CHEPA working paper series no. 96-22 |
| Description: | Bernie O'Brien ... [et al.]. Includes bibliographical references (p. 25-28). |
| URI: | http://hdl.handle.net/11375/16943 |
| Appears in Collections: | CHEPA Working Paper Series |
Files in This Item:
There are no files associated with this item.
Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.
